US demand for biocompatible materials will grow 6.6 percent annually through 2010. Synthetic polymers will remain dominant based on quality, performance and cost advantages in most applications. Ceramics will grow the fastest, driven by improved properties and processing ease. Hyaluronic acid and collagen will pace the natural polymer segment.
This study analyzes the $2.7 billion US biocompatible materials industry. It presents historical demand data (1995, 2000, 2005) and forecasts to 2010 and 2015 by material (e.g., TPEs, PVC, fluoropolymers, polyurethane, silicone, LDPE, cellulose polymers, collagen, starch blends, precious metals, stainless steel, porcelain, alumina, zirconia); and by application (e.g., surgical appliances and supplies, surgical and medical instruments, dental products, drug delivery).
The study also considers market environment factors, evaluates company market share, and profiles 35 major industry players including General Electric, Allegheny Technologies, Bayer, PolyOne, DuPont, BASF, OxyVinyls, Exxon Mobil, Georgia Gulf, and Dow Chemical.